8942.TWO · XXENTRIA
Taiwan · RS rating 57 · As of 2026-10-08
| Price | 40.20 TWD |
|---|---|
| 1-day change | +0.0% |
| RS rating (overall / 1M / 3M / 12M) | 57 / 15 / 70 / 58 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 39 / 27 / 51 |
| Industry group (rank) | Medical-Ethical Drugs (–) |
| EPS growth Q/Q | +186.7% |
| Sales growth Q/Q | +25.2% |
| Distance from 52-week high | +12.6% |
| Market cap (USD) | $249.4M |